CRISPR

CRISPR1-sema3fb

ID
ZDB-CRISPR-190204-2
Name
CRISPR1-sema3fb
Previous Names
None
Target
Sequence
5' - GAAGGACAAGAAGACCCGCG - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
ca305 sema3fb
ca306 sema3fb
Expression
Gene expression in Wild Types + CRISPR1-sema3fb
No data available
Phenotype
Phenotype resulting from CRISPR1-sema3fb
No data available
Phenotype of all Fish created by or utilizing CRISPR1-sema3fb
Phenotype Fish Conditions Figures
pericardium increased area, abnormal sema3fbca305/ca305 standard conditions Fig. 2 with image from Halabi et al., 2022
cardiac ventricle decreased volume, abnormal sema3fbca305/ca305 standard conditions Fig. 3 with image from Halabi et al., 2022
atrioventricular canal cardiac muscle cell tbx2b expression increased distribution, abnormal sema3fbca305/ca305 standard conditions Fig. 6 with image from Halabi et al., 2022
atrium cardiac muscle cell ab-s46 labeling spatial pattern, abnormal sema3fbca305/ca305 standard conditions Fig. 4 with image from Halabi et al., 2022
endocardium nfatc1 expression decreased distribution, abnormal sema3fbca305/ca305 standard conditions Fig. 6 with image from Halabi et al., 2022
heart zn-8 labeling spatial pattern, abnormal sema3fbca305/ca305 standard conditions Fig. 5 with image from Halabi et al., 2022
cardiac ventricle myh7 expression decreased distribution, abnormal sema3fbca305/ca305 standard conditions Fig. 4 with image from Halabi et al., 2022
cardiac ventricle cardiac muscle cell decreased area, abnormal sema3fbca305/ca305 standard conditions Fig. 5 with image,  Fig. 7 with image from Halabi et al., 2022
cardiac ventricle decreased thickness, abnormal sema3fbca305/ca305 standard conditions Fig. 2 with image from Halabi et al., 2022
atrium myh6 expression decreased distribution, abnormal sema3fbca305/ca305 standard conditions Fig. 4 with image from Halabi et al., 2022
heart contraction decreased rate, abnormal sema3fbca305/ca305 standard conditions Fig. 3 with image,  Fig. 7 with image from Halabi et al., 2022
pericardium edematous, abnormal sema3fbca305/ca305 standard conditions Fig. 2 with image from Halabi et al., 2022
heart ab-mf20 labeling spatial pattern, abnormal sema3fbca305/ca305 standard conditions Fig. 5 with image from Halabi et al., 2022
heart tube myh6 expression spatial pattern, abnormal sema3fbca305/ca305 standard conditions Fig. 5 with image from Halabi et al., 2022
heart bmp4 expression spatial pattern, abnormal sema3fbca305/ca305 standard conditions Fig. 5 with image from Halabi et al., 2022
cardiac ventricle increased area, abnormal sema3fbca305/ca305 standard conditions Fig. 4 with image from Halabi et al., 2022
cardiac ventricle decreased length, abnormal sema3fbca305/ca305 standard conditions Fig. 4 with image from Halabi et al., 2022
cardiac ventricle decreased perimeter, abnormal sema3fbca305/ca305 standard conditions Fig. 5 with image,  Fig. 7 with image from Halabi et al., 2022
heart tnnt2a expression spatial pattern, abnormal sema3fbca305/ca305 standard conditions Fig. 5 with image from Halabi et al., 2022
heart tnnt2a expression decreased distribution, abnormal sema3fbca305/ca305 standard conditions Fig. 4 with image from Halabi et al., 2022
atrium decreased area, abnormal sema3fbca305/ca305 standard conditions Fig. 4 with image,  Fig. 7 with image from Halabi et al., 2022
atrioventricular valve asymmetrical, abnormal sema3fbca305/ca305 standard conditions Fig. 6 with image from Halabi et al., 2022
heart anterior-posterior axis decreased length, abnormal sema3fbca305/ca305 standard conditions Fig. 4 with image from Halabi et al., 2022
cardiac ventricle myh7 expression decreased distribution, abnormal sema3fbca306/ca306 standard conditions Fig. 4 with image from Halabi et al., 2022
atrium myh6 expression decreased distribution, abnormal sema3fbca306/ca306 standard conditions Fig. 4 with image from Halabi et al., 2022
pericardium edematous, abnormal sema3fbca306/ca306 standard conditions Fig. 2 with image from Halabi et al., 2022
cardiac ventricle decreased length, abnormal sema3fbca306/ca306 standard conditions Fig. 4 with image from Halabi et al., 2022
cardiac ventricle increased area, abnormal sema3fbca306/ca306 standard conditions Fig. 4 with image from Halabi et al., 2022
heart tnnt2a expression spatial pattern, abnormal sema3fbca306/ca306 standard conditions Fig. 5 with image from Halabi et al., 2022
atrium decreased area, abnormal sema3fbca306/ca306 standard conditions Fig. 4 with image from Halabi et al., 2022
heart anterior-posterior axis decreased length, abnormal sema3fbca306/ca306 standard conditions Fig. 4 with image from Halabi et al., 2022
heart tnnt2a expression decreased distribution, abnormal sema3fbca306/ca306 standard conditions Fig. 4 with image from Halabi et al., 2022
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.